美通社

2024-10-03 14:00

Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients

  • The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to breast cancer.

MADRID, Oct. 3, 2024 /PRNewswire/ -- Veritas Genetics, in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and the Tor Vergata University Hospital, has published the results of an innovative pilot study demonstrating the importance of polygenic risk scores (PRS) in identifying and managing women with a high risk of developing breast cancer.

This groundbreaking study, led by Professor Giuseppe Novelli from the University of Tor Vergata in collaboration with key members of Veritas' medical-scientific team (Dr. Vincenzo Cirigliano, Dr. Luis Izquierdo, Giuliana Longo, and Bibiana Palao), suggests that PRS, combined with the assessment of known pathogenic variants, can provide a more accurate risk evaluation for both carriers and non-carriers of mutations in genes such as BRCA1, BRCA2, PALB2, and ATM.

Key Findings of the Study

The study, published in the Journal of Personalized Medicine, evaluated women with a family history of breast cancer, demonstrating that PRS significantly improves the accuracy of individual risk prediction. This is particularly relevant for women who are non-carriers of pathogenic variants in susceptibility genes. For carriers of mutations in genes like BRCA1 and BRCA2, PRS offers a complementary approach that helps refine personalized management and prevention strategies.

According to Dr. Izquierdo, Chief Medical Officer at Veritas, "This study reaffirms the clinical value of genomic tools in personalizing preventive medicine. The use of PRS, along with traditional genetic evaluation, allows healthcare professionals to offer more precise and tailored care to the individual needs of each patient, ultimately improving long-term outcomes."

An Essential Tool for Personalized Medicine

PRS has the potential to transform how cancer risk is assessed and managed in patients with a family history of the disease. Dr. Izquierdo, added: "Polygenic risk scoring not only provides a deeper evaluation of genetic risk but also redefines how we understand cancer susceptibility in families with a history of the disease. This tool is key to the future of personalized medicine and the proactive management of complex conditions like breast cancer."

About Veritas Genetics

Veritas Genetic leads the implementation of advanced genomic solutions, focusing on preventive and personalized medicine. Through partnerships with top-tier academic institutions, Veritas continues to drive innovation aimed at improving health and well-being.

www.veritasint.com

https://www.mdpi.com/2975338 

source: Veritas Genetics

【你點睇?】特朗普當局擬關閉美國國家民主基金會,你認為若其關閉是否可促進全球和平穩定?► 立即投票

人氣文章
最近7天
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
3
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
4
高息定存 | 花旗3個月港元定存息加至4厘,信銀國際3.88厘
5
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
6
一本萬利 | 2025年的五個「勿」(有片)
7
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
8
互聯支付 | 黃俊碩:轉數快與IBPS互聯支付所產生的發展契機
9
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
10
電騙 | 黃俊碩:多管齊下,防治內地留學生受騙
11
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
12
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
13
洪灝專訪 | 淘寶衝擊巨大,港樓價未反映大周期拐點(有片)
14
專訪|洪灝:美股更大跌幅在前面,恐需習慣4%通脹(有片)
15
習近平應約與特朗普通電話,特:冀盡快與習見面
16
新世界 | 摩通:新世界若債務違約或打開行業「潘朵拉盒子」
17
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
18
【FOCUS】螺絲殼裏做道場,DeepSeek致勝啟示
19
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
20
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
21
雷賢達觀點 | 香港篇:恒指年波幅料六千點,港須全面融入大灣區
22
DeepSeek推出即上蘋果中國區榜首,能力直追OpenAI
23
高息定存 | 一周高息合集,部分銀行逆市加息,南商3個月加至3.8厘
24
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
25
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
26
港股 | 蕭猷華:春節假後,恒指逐步上望21000點
27
特朗普就職 | 特朗普上台後行動列表
28
馬斯克明拆特朗普台,指其星際之門計劃「假大空」
29
【FOCUS】侵侵呼籲全球「降息」,日銀祭18年最激進加息
30
高息定存 | 富邦一周港元定存高達9.88厘,一個月4.88厘
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【蛇年行大運 新年好賞「飾」】etnet賞太歲開運趨吉避凶神器

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老